In Brief:
Kaseman et al. report the epidemiologic, clinical,microbiological and treatment results in 126 patients with 132 episodes of group B streptococcal bacteremia. Diabetes mellitus was the most common predisposing illness. Clinical manifestations ranged from primary bacteremia to severe bone and joint infections. There was a 13% mortality with this generally antimicrobially susceptible organism even in the first decade of the 21st century.
